Jean-Paul Kress
Chief Executive Officer at MORPHOSYS AG
Net worth: - $ as of 2024-03-30
Network origin in Jean-Paul Kress first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
32
| Public Company | Biotechnology | 32 |
23
| Public Company | Pharmaceuticals: Major | 23 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.
17
| Subsidiary | Medical Specialties | 17 |
École Normale Supérieure
11
| College/University | Other Consumer Services | 11 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.
11
| Subsidiary | Biotechnology | 11 |
ERYTech Pharma SA
 ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.
10
| Extinct | Pharmaceuticals: Major | 10 |
| Public Company | Pharmaceuticals: Major | 10 | |
| Public Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Jean-Paul Kress via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| PEPSICO, INC. | Food: Specialty/Candy | Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Public Communications Contact | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Human Resources Officer Human Resources Officer | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder Founder President | |
| PERCHERON THERAPEUTICS LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| TIGENIX NV | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Human Resources Officer | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Director/Board Member Human Resources Officer Chief Tech/Sci/R&D Officer | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Masters Business Admin | |
| University of Cambridge | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| Suffolk University | College/University | Undergraduate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Illinois | College/University | Doctorate Degree Undergraduate Degree | |
| University of Vermont | College/University | Undergraduate Degree Doctorate Degree | |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Investment Managers | Private Equity Investor Private Equity Investor | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| The Johannes Gutenberg University of Mainz | College/University | Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Graduate Degree Graduate Degree | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | Human Resources Officer General Counsel | |
| UMass Chan Medical School | College/University | Doctorate Degree Graduate Degree | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Braeburn Pharmaceuticals SPRL
 Braeburn Pharmaceuticals SPRL Medical SpecialtiesHealth Technology Braeburn Pharmaceuticals SPRL develops and commercializes medical products. It’s a pharmaceutical company focused on novel, long-acting implantable and injectable therapies for serious neurological and psychiatric disorders, including addiction, pain, and schizophrenia. The firm offers Probuohine, CAM2038q1w, CAM2038q4w and Risperdone implant. The company was founded in 2012 and is headquartered in Road Town, British Virgin Islands. | Medical Specialties | Chairman Corporate Officer/Principal | |
| Boston College Law School | College/University | Graduate Degree Graduate Degree | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree Masters Business Admin | |
Carrick Therapeutics Ltd.
 Carrick Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Carrick Therapeutics Ltd. manufactures cancer therapeutics. The company is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Chairman Chairman | |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Tusk Therapeutics Ltd.
 Tusk Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Tusk Therapeutics Ltd. operates as a immuno-oncology company, focused on discovering and developing therapeutic antibodies. It provides immune modulating cancer therapeutics. The company is headquartered in Stevenage, the United kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| STOKE THERAPEUTICS, INC. | Biotechnology | Chairman Director/Board Member Human Resources Officer Corporate Officer/Principal General Counsel | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director of Finance/CFO Chief Operating Officer | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Director/Board Member | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer |
Statistics
International
| United States | 37 |
| Germany | 5 |
| Ireland | 3 |
| United Kingdom | 3 |
| Denmark | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 16 |
| Commercial Services | 3 |
| Finance | 3 |
| Consumer Non-Durables | 2 |
Operational
| Director/Board Member | 270 |
| Corporate Officer/Principal | 203 |
| Independent Dir/Board Member | 84 |
| Chairman | 70 |
| Undergraduate Degree | 67 |
Most connected contacts
| Insiders | |
|---|---|
| Seth Harrison | 43 |
| George Golumbeski | 36 |
| Anne Bouverot | 33 |
| Luc Dochez | 26 |
| Didier Hoch | 24 |
| Sven Arne Andréasson | 24 |
| Burt Adelman | 23 |
| Wendy Johnson | 23 |
| Frank Morich | 21 |
| Aaron Kantoff | 19 |
| Christophe Jurczak | 19 |
| Mario David Saltarelli | 17 |
| Catherine Stehman-Breen | 16 |
| Jens Holstein | 14 |
| Paul Clancy | 14 |
- Stock Market
- Insiders
- Jean-Paul Kress
- Company connections